Market Overview:
The Global Next Generation Sequencing Market size was valued at USD 6.23 billion in 2021 and is projected to register a valuation of USD 23.18 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 15.2% over the forecast period 2022-2030.
Market Introduction:
The increasing use of NGS technology in clinical diagnosis, cost, speed, and accuracy of this sequencing method are a major factors driving the growth of the market. NGS diagnostic technology has the potential benefit of determining the genetic sequence of the virus and helping scientists understand the mutation.
Next Generation Sequencing (NGS) is a powerful platform that has enabled the sequencing of thousands to millions of DNA molecules at the same time. This powerful tool is revolutionizing fields such as personalized medicine, clinical diagnostics, and genetic diseases by offering a high throughput option with the capability to sequence multiple individuals at the same time. Sanger Sequencing, first developed in the 1900s, is the gold standard for DNA sequencing and it is still used today widely for routine sequencing applications and to validate.
It takes advantage of a high-fidelity DNA-dependent polymerase to generate a complimentary copy to a single-stranded DNA template.
Covid-19 Impact Analysis by Market Business Insights:
The outbreak of COVID-19 and the subsequent extent of lockdown have impacted the next-generation sequencing market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times including production shutdowns, transportation, healthcare, supply chain disruptions, cost increases, and workforce disruptions, which negatively affect the next-generation sequencing industry in terms of revenue.
During the COVID-19 pandemic, government officials around the world are working relentlessly with the private sector to market NGS technology as a potential diagnostic tool. As next generation sequencing plays an essential role in clinical laboratories to fight against the COVID-19 pandemic. Researchers and scientists fought against the COVID-19 pandemic together to identify a new strain of coronavirus from organisms with no prior knowledge.
However, the COVID-19 pandemic had a positive impact on the global market, due to increased research and development activities by the major players to use next-generation sequencing technologies for the diagnosis of COVID-19 infections.
What are the Global Next Generation Sequencing Market Drivers?
The growing demand for NGS technology by pharmaceutical and biopharmaceutical companies and rising technological advancements in next-generation sequencing in developed countries are the factors propelling the market.
The rising population, and rising incidence of cancer and infectious diseases are expected to boost the next-generation sequencing market owing to the increasing applications of next-generation sequencing in the fields of transmissible diseases and oncology.
The rise in the development of personalized drugs, NGS bioinformatics solutions, growth in pre-sequencing, and cloud computing are some of the opportunities for the global next-generation sequencing market. However, the management and storage of the huge data generated by sequencing and its interpretation pose some challenges to the industry.
Who are the Major Companies in the Global Next Generation Sequencing Market?
- Illumina
- F. Hoffman-La Roche Ltd.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies
- PierianDx
- Genomatix GmbH
- DNASTAR, Inc.
- Perkin Elmer, Inc.
- Eurofins GATC Biotech GmbH
- BGI
Global Next Generation Sequencing Market Segmentation:
The Global next-generation sequencing market is segmented by orbit type, application, end-user, and region. By technology Sequencing by Synthesis, Sequencing by Ligation, Ion Semiconductor Sequencing, Pyrosequencing, Other Technologies. By application Diagnostics, Reproductive Health, Agriculture and Animal Research, Biomarkers and Cancer, and Other Applications. By region Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.
By Technology:
Sequencing by synthesis segment is leading the overall next-generation sequencing market in 2021 and is expected to grow at the fastest CAGR during the forecast period.
- Sequencing by Synthesis
- Sequencing by Ligation
- Ion Semiconductor Sequencing
- Pyrosequencing
- Other Technologies
By Application:
On the basis of application, clinical applications are the largest segment of the market, primarily due to the growing incidence of cancer and the increasing volume of diagnostic procedures and treatment rates for the disease.
- Diagnostics
- Reproductive Health
- Agriculture and Animal Research
- Biomarkers and Cancer
- Other Applications
Regional Analysis by Market Business Insights:
The global next-generation sequencing market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.
North America will witness rapid growth in the market.
North America is expected to hold lion's share of the market in the near future. The US region is a major market for the key players. Next-generation sequencing technology is acquiring popularity as a routine clinical diagnostic test, particularly with the COVID-19 pandemic in this region.
The equipment/Instrument segment in the US is expected to rapidly grow in the forecast period from 2022 to 2030 because of a large number of manufacturers who are distributing Instruments to various research laboratories and others.
Report Coverage:
Market Segmentation:
By Technology
- Sequencing by Synthesis
- Sequencing by Ligation
- Ion Semiconductor Sequencing
- Pyrosequencing
- Other Technologies
By Application
- Diagnostics
- Reproductive Health
- Agriculture and Animal Research
- Biomarkers and Cancer
- Other Applications
By Region
North America
Europe
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa